Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.

@article{Ehrenreich2007ExploringRH,
  title={Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.},
  author={Hannelore Ehrenreich and Benjamin Fischer and Christine Norra and Felix Schellenberger and Nike Stender and Michael Stiefel and A K Sir{\'e}n and Walter Paulus and Klaus-Armin Nave and Ralf Gold and Claudia Bartels},
  journal={Brain : a journal of neurology},
  year={2007},
  volume={130 Pt 10},
  pages={2577-88}
}
The neurodegenerative aspects of chronic progressive multiple sclerosis (MS) have received increasing attention in recent years, since anti-inflammatory and immunosuppressive treatment strategies have largely failed. However, successful neuroprotection and/or neuroregeneration in MS have not been demonstrated yet. Encouraged by the multifaceted neuroprotective effects of recombinant human erythropoietin (rhEPO) in experimental models, we performed an investigator-driven, exploratory open label… CONTINUE READING